Dengue fever future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Dengue fever}} {{CMG}} ==Overview== ==Emerging treatments== Emerging evidence suggests that mycophenolic acid and ribivirin inhibit dengue replication. Initial ex..." |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
== | ==Future or Investigational Therapies== | ||
Emerging evidence suggests that [[mycophenolic acid]] and [[ribivirin]] inhibit dengue replication. Initial experiments showed a fivefold increase in defective viral RNA production by cells treated with each drug.<sup>[http://vir.sgmjournals.org/cgi/content/full/87/7/1947]</sup> ''In vivo'' studies, however, have not yet been done. | Emerging evidence suggests that [[mycophenolic acid]] and [[ribivirin]] inhibit dengue replication. Initial experiments showed a fivefold increase in defective viral RNA production by cells treated with each drug.<sup>[http://vir.sgmjournals.org/cgi/content/full/87/7/1947]</sup> ''In vivo'' studies, however, have not yet been done. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 14:23, 28 August 2012
|
Dengue Fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dengue fever future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Dengue fever future or investigational therapies |
|
Dengue fever future or investigational therapies in the news |
|
Risk calculators and risk factors for Dengue fever future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Future or Investigational Therapies
Emerging evidence suggests that mycophenolic acid and ribivirin inhibit dengue replication. Initial experiments showed a fivefold increase in defective viral RNA production by cells treated with each drug.[2] In vivo studies, however, have not yet been done.